How DOE Decides Who Gets The SSC

WASHlNGTON—In less than six weeks, energy Secretary John Herrington will announce where he plans to build the $5.4 billion Superconducting Supercollider Will the decision be remembered as another flagrant example of pork-barrell science ? Or will the secretary actually manage to avoid politics and make his decision on technical and scientiftc merits. Most observers feel that the Department of Energy must avoid even the appearance of political patronage if it wants its decision to be ac

Written byJeffrey Mervis
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

WASHlNGTON—In less than six weeks, energy Secretary John Herrington will announce where he plans to build the $5.4 billion Superconducting Supercollider Will the decision be remembered as another flagrant example of pork-barrell science ? Or will the secretary actually manage to avoid politics and make his decision on technical and scientiftc merits.

Most observers feel that the Department of Energy must avoid even the appearance of political patronage if it wants its decision to be acceptable to Congress. “[Energy John] Herrington doesn’t want to make a decision that is controversial,” says Peter Sloan. a Washington lobbyist hired by Arizona to handle congressional relations. “He wants the selection process to be completely above suspicion so that it doesn’t become a political issue." Adds Ed Forgotson, a Washington lobbyist for North Carolina, "any whiff of politics will quse queer the deal, and he knows it.,"

So how will Herrington arrive at his ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies